The spectrum of left main coronary artery disease: variables affecting patient selection, management, and death.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 6765978)

Published in J Thorac Cardiovasc Surg on January 01, 1980

Authors

E L Jones, S B King, J M Craver, J S Douglas, J A Kaplan, E A Morgan, E M Brown, J M Bradford, C R Hatcher

Articles by these authors

Genetics of bacterial ribosomes. Annu Rev Genet (1977) 5.64

Characterization of hybrid plasmids carrying individual ribosomal ribonucleic acid transcription units of Escherichia coli. J Bacteriol (1977) 5.37

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65

Variations in experience in obtaining local ethical approval for participation in a multi-centre study. QJM (2003) 4.53

Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med (1995) 4.19

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13

Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol (1999) 3.63

Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation (1988) 3.09

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65

Atraumatic so-called "spontaneous" rupture of the esophagus. A review of 47 personal cases with comments on a new method of surgical therapy. J Thorac Cardiovasc Surg (1970) 2.63

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58

Identification of spacer tRNA genes in individual ribosomal RNA transcription units of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.51

Overlapping functions of the Saccharomyces cerevisiae Mre11, Exo1 and Rad27 nucleases in DNA metabolism. Genetics (2001) 2.46

Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg (1999) 2.37

Contractile responses of the guinea-pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs. J Pharmacol Exp Ther (1975) 2.36

Early management of battle casualties in Vietnam. An analysis of 1,011 consecutive cases treated at a mobile army surgical hospital. Arch Surg (1968) 2.34

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab (1996) 2.33

Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31

Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J (2007) 2.17

Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature (1999) 2.17

Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem (1999) 2.16

Vitamins C and E inhibit O2- production in the pig coronary artery. Circulation (1997) 2.14

Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res (1997) 2.11

Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med (1997) 2.09

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation (1989) 2.07

L-amino acid sensing by the extracellular Ca2+-sensing receptor. Proc Natl Acad Sci U S A (2000) 2.02

Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation (1986) 1.99

Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem (1998) 1.98

Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry. Circulation (1993) 1.98

601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg (1999) 1.96

The NMR multi-transmit phased array: a Cartesian feedback approach. J Magn Reson (2004) 1.93

Some rRNA operons in E. coli have tRNA genes at their distal ends. Cell (1978) 1.91

Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up. Circulation (1992) 1.89

Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem (1995) 1.86

Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation (1997) 1.83

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation (1999) 1.82

Immunoglobulin-containing cells in human tonsils as demonstrated by immunohistochemistry. Clin Exp Immunol (1977) 1.81

Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Engl J Med (1987) 1.80

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76

Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72

Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol (1998) 1.72

Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71

Intercellular communication mediated by the extracellular calcium-sensing receptor. Nat Cell Biol (2000) 1.68

Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis (1984) 1.66

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation (1995) 1.66

Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation (1993) 1.63

Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol (1998) 1.62

Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Circulation (1990) 1.62

Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A (1995) 1.61

Clostridium difficile in acute and long-stay elderly patients. Age Ageing (1988) 1.60

Nitroglycerin infusion during coronary-artery surgery. Anesthesiology (1976) 1.60

Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem (1996) 1.59

Airway constriction in guinea pigs: interaction of histamine and autonomic drugs. J Pharmacol Exp Ther (1973) 1.59

Insertions of Tn 10 into an E. coli ribosomal RNA operon are incompletely polar. Cell (1980) 1.59

Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59

Goose parvovirus in England and Wales. Vet Rec (2004) 1.57

Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat. Ann Thorac Surg (1994) 1.57

Nomenclature of the proteins of cows' milk--sixth revision. J Dairy Sci (2004) 1.55

Prostaglandin regulation of airway smooth muscle tone. Nat New Biol (1973) 1.55

Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab (1998) 1.55

Single-stage complete muscle flap closure of the postpneumonectomy empyema space: a new method and possible solution to a disturbing complication. Ann Thorac Surg (1984) 1.55

Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem (1992) 1.54

Coronary revascularization in a patient with porcelain aorta and calcified great vessels. Ann Thorac Surg (1993) 1.54

A homestyle delivery program in a university hospital. J Fam Pract (1979) 1.53

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation (1988) 1.52

In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation (1985) 1.52

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol (1993) 1.51

Antitermination mechanisms in rRNA operons of Escherichia coli. J Bacteriol (1986) 1.51

Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun (2001) 1.48

Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation (1993) 1.46

Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann Thorac Surg (2000) 1.46

Inhibition of human internal mammary artery contractions. An in vitro study of vasodilators. J Thorac Cardiovasc Surg (1992) 1.46

Intracoronary beta-radiation exacerbates long-term neointima formation in balloon-injured pig coronary arteries. Circulation (2001) 1.46

Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab (1983) 1.45

Nicardipine, a new intravenous calcium antagonist: a review of its pharmacology, pharmacokinetics, and perioperative applications. J Cardiothorac Anesth (1989) 1.44

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol (1992) 1.44